Cargando…
Anticancer effects of Morinda lucida and Annona muricata on immunomodulations of Melatonin, tumor necrosis factor-alpha and p53 concentrations in lead acetate-induced toxicity in rats
OBJECTIVES: Lead poisoning accounts for about 0.6% of global burden of disease. Lead-induced toxicity is through confinement of oxidative stress in affected organs. We evaluated the effects of MLF1 (extracted from Morinda lucida leaves) and AMF1 (extracted from Annona muricata leaves) on lipid perox...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Qassim Uninversity
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265306/ https://www.ncbi.nlm.nih.gov/pubmed/34285685 |
_version_ | 1783719744286752768 |
---|---|
author | Akinlolu, A. A. Ameen, M. O. Oyewopo, A. O. Kadir, R. E. Ahialaka, O. Tijani, S. Ogungbesan, O. Bebeyi, R. Adebayo, S. Amoo, T. Abdulazeez, M. |
author_facet | Akinlolu, A. A. Ameen, M. O. Oyewopo, A. O. Kadir, R. E. Ahialaka, O. Tijani, S. Ogungbesan, O. Bebeyi, R. Adebayo, S. Amoo, T. Abdulazeez, M. |
author_sort | Akinlolu, A. A. |
collection | PubMed |
description | OBJECTIVES: Lead poisoning accounts for about 0.6% of global burden of disease. Lead-induced toxicity is through confinement of oxidative stress in affected organs. We evaluated the effects of MLF1 (extracted from Morinda lucida leaves) and AMF1 (extracted from Annona muricata leaves) on lipid peroxidation and immunomodulations of Melatonin, tumor necrosis factor-alpha (TNF-α), and p53 proteins in lead acetate (LA)-induced toxicity in rats. METHODS: Sixty adult female rats were randomly divided into 12 groups (n = 5). Groups 1 and 2 received physiological saline and 100 mg/kg bodyweight of LA, respectively, for 5 weeks. Groups 3–6 received 100 mg/kg bodyweight LA for 2 weeks, followed by treatments with 7.5 and 15 mg/kg bodyweight of MLF1, and 7.5 and 10 mg/kg bodyweight of AMF1, respectively, for 3 weeks. Groups 7–10 received 7.5 and 15 mg/kg bodyweight of MLF1, 7.5 and 10 mg/kg bodyweight of AMF1, respectively, for 5 weeks. Groups 11–12 received co-administrations of 100 mg/kg bodyweight LA with 15 mg/kg bodyweight MLF1 and 10 mg/kg bodyweight of AMF1, respectively, for 5 weeks. Drugs and extracts were administered orally. Consequently, liver histopathology (Hematoxylin and Eosin), sera Melatonin, and TNF-α (enzyme-linked immunosorbent assay [ELISA]) levels were evaluated. Malondialdehyde (MDA) (thiobarbituric acid assay) and p53 (ELISA) levels were evaluated in liver homogenates. Data were statistically analyzed (P ≤ 0.05). RESULTS: Results showed normal liver histology in all Groups. Statistical analyses showed significant (P ≤ 0.05) and non-significant decreased levels (P ≥ 0.05) of MDA, TNF-α and p53 in Groups 3-12, compared with Group 2. Furthermore, results showed significant (P ≤ 0.05) and non-significant increased Melatonin levels (P ≥ 0.05) in Groups 4–12 compared with Group 2. CONCLUSION: This study confirmed that MLF1 and AMF1 confer a degree of antioxidant, anticancer and hepato-protetive potentials against LA-induced toxicity in rats. |
format | Online Article Text |
id | pubmed-8265306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Qassim Uninversity |
record_format | MEDLINE/PubMed |
spelling | pubmed-82653062021-07-19 Anticancer effects of Morinda lucida and Annona muricata on immunomodulations of Melatonin, tumor necrosis factor-alpha and p53 concentrations in lead acetate-induced toxicity in rats Akinlolu, A. A. Ameen, M. O. Oyewopo, A. O. Kadir, R. E. Ahialaka, O. Tijani, S. Ogungbesan, O. Bebeyi, R. Adebayo, S. Amoo, T. Abdulazeez, M. Int J Health Sci (Qassim) Original Article OBJECTIVES: Lead poisoning accounts for about 0.6% of global burden of disease. Lead-induced toxicity is through confinement of oxidative stress in affected organs. We evaluated the effects of MLF1 (extracted from Morinda lucida leaves) and AMF1 (extracted from Annona muricata leaves) on lipid peroxidation and immunomodulations of Melatonin, tumor necrosis factor-alpha (TNF-α), and p53 proteins in lead acetate (LA)-induced toxicity in rats. METHODS: Sixty adult female rats were randomly divided into 12 groups (n = 5). Groups 1 and 2 received physiological saline and 100 mg/kg bodyweight of LA, respectively, for 5 weeks. Groups 3–6 received 100 mg/kg bodyweight LA for 2 weeks, followed by treatments with 7.5 and 15 mg/kg bodyweight of MLF1, and 7.5 and 10 mg/kg bodyweight of AMF1, respectively, for 3 weeks. Groups 7–10 received 7.5 and 15 mg/kg bodyweight of MLF1, 7.5 and 10 mg/kg bodyweight of AMF1, respectively, for 5 weeks. Groups 11–12 received co-administrations of 100 mg/kg bodyweight LA with 15 mg/kg bodyweight MLF1 and 10 mg/kg bodyweight of AMF1, respectively, for 5 weeks. Drugs and extracts were administered orally. Consequently, liver histopathology (Hematoxylin and Eosin), sera Melatonin, and TNF-α (enzyme-linked immunosorbent assay [ELISA]) levels were evaluated. Malondialdehyde (MDA) (thiobarbituric acid assay) and p53 (ELISA) levels were evaluated in liver homogenates. Data were statistically analyzed (P ≤ 0.05). RESULTS: Results showed normal liver histology in all Groups. Statistical analyses showed significant (P ≤ 0.05) and non-significant decreased levels (P ≥ 0.05) of MDA, TNF-α and p53 in Groups 3-12, compared with Group 2. Furthermore, results showed significant (P ≤ 0.05) and non-significant increased Melatonin levels (P ≥ 0.05) in Groups 4–12 compared with Group 2. CONCLUSION: This study confirmed that MLF1 and AMF1 confer a degree of antioxidant, anticancer and hepato-protetive potentials against LA-induced toxicity in rats. Qassim Uninversity 2021 /pmc/articles/PMC8265306/ /pubmed/34285685 Text en Copyright: © International Journal of Health Sciences https://creativecommons.org/licenses/by-nc-sa/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Akinlolu, A. A. Ameen, M. O. Oyewopo, A. O. Kadir, R. E. Ahialaka, O. Tijani, S. Ogungbesan, O. Bebeyi, R. Adebayo, S. Amoo, T. Abdulazeez, M. Anticancer effects of Morinda lucida and Annona muricata on immunomodulations of Melatonin, tumor necrosis factor-alpha and p53 concentrations in lead acetate-induced toxicity in rats |
title | Anticancer effects of Morinda lucida and Annona muricata on immunomodulations of Melatonin, tumor necrosis factor-alpha and p53 concentrations in lead acetate-induced toxicity in rats |
title_full | Anticancer effects of Morinda lucida and Annona muricata on immunomodulations of Melatonin, tumor necrosis factor-alpha and p53 concentrations in lead acetate-induced toxicity in rats |
title_fullStr | Anticancer effects of Morinda lucida and Annona muricata on immunomodulations of Melatonin, tumor necrosis factor-alpha and p53 concentrations in lead acetate-induced toxicity in rats |
title_full_unstemmed | Anticancer effects of Morinda lucida and Annona muricata on immunomodulations of Melatonin, tumor necrosis factor-alpha and p53 concentrations in lead acetate-induced toxicity in rats |
title_short | Anticancer effects of Morinda lucida and Annona muricata on immunomodulations of Melatonin, tumor necrosis factor-alpha and p53 concentrations in lead acetate-induced toxicity in rats |
title_sort | anticancer effects of morinda lucida and annona muricata on immunomodulations of melatonin, tumor necrosis factor-alpha and p53 concentrations in lead acetate-induced toxicity in rats |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265306/ https://www.ncbi.nlm.nih.gov/pubmed/34285685 |
work_keys_str_mv | AT akinloluaa anticancereffectsofmorindalucidaandannonamuricataonimmunomodulationsofmelatonintumornecrosisfactoralphaandp53concentrationsinleadacetateinducedtoxicityinrats AT ameenmo anticancereffectsofmorindalucidaandannonamuricataonimmunomodulationsofmelatonintumornecrosisfactoralphaandp53concentrationsinleadacetateinducedtoxicityinrats AT oyewopoao anticancereffectsofmorindalucidaandannonamuricataonimmunomodulationsofmelatonintumornecrosisfactoralphaandp53concentrationsinleadacetateinducedtoxicityinrats AT kadirre anticancereffectsofmorindalucidaandannonamuricataonimmunomodulationsofmelatonintumornecrosisfactoralphaandp53concentrationsinleadacetateinducedtoxicityinrats AT ahialakao anticancereffectsofmorindalucidaandannonamuricataonimmunomodulationsofmelatonintumornecrosisfactoralphaandp53concentrationsinleadacetateinducedtoxicityinrats AT tijanis anticancereffectsofmorindalucidaandannonamuricataonimmunomodulationsofmelatonintumornecrosisfactoralphaandp53concentrationsinleadacetateinducedtoxicityinrats AT ogungbesano anticancereffectsofmorindalucidaandannonamuricataonimmunomodulationsofmelatonintumornecrosisfactoralphaandp53concentrationsinleadacetateinducedtoxicityinrats AT bebeyir anticancereffectsofmorindalucidaandannonamuricataonimmunomodulationsofmelatonintumornecrosisfactoralphaandp53concentrationsinleadacetateinducedtoxicityinrats AT adebayos anticancereffectsofmorindalucidaandannonamuricataonimmunomodulationsofmelatonintumornecrosisfactoralphaandp53concentrationsinleadacetateinducedtoxicityinrats AT amoot anticancereffectsofmorindalucidaandannonamuricataonimmunomodulationsofmelatonintumornecrosisfactoralphaandp53concentrationsinleadacetateinducedtoxicityinrats AT abdulazeezm anticancereffectsofmorindalucidaandannonamuricataonimmunomodulationsofmelatonintumornecrosisfactoralphaandp53concentrationsinleadacetateinducedtoxicityinrats |